GSK logo

GSK plc (GSK)

Profile

Full Name

GSK plc

Ticker

NYSE: GSK

Exchange

NYSE

Sector

Healthcare

Industry

General Drug Manufacturers

Country

United Kingdom

IPO

March 28, 1980

Indexes

Not included

Website

http://www.gsk.com

Employees

68629

Key Details

Price

$37.97(-0.68%)

Market cap

Last Dividend

$0.43

TTM Dividend yield

4.21%

Annual revenue

$40.10B(+6.26% YoY)

Annual EPS

$1.59(-46.72% YoY)

PE ratio

19.69

Next earnings date

Jul 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $37.97
    GSK price is $37.97

    30-Day Relative Volume

    0.68
    GSK 30-day relative volume is 0.68

    Price Performance

    Price Today change

    -0.68%
    GSK price is down -0.68% today

    Price YTD change

    +12.27%
    GSK price is up +12.27% since January 1st

    Price 1-year change

    -2.82%
    GSK price is down -2.82% year-on-year

    Price 3-year change

    -9.94%
    GSK price is down -9.94% over the past 3 years

    Price Range

    Price All-time high

    $77.04
    GSK price is currently -50.72% below its historical high of $77.04

    Price 3-year low

    $28.47
    GSK price is currently +33.37% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $77.17B
    GSK market capitalization is $77.17 billion

    Market cap 3-year change

    -10%
    GSK market capitalization is down -10% over the past 3 years

    Market cap All-time high

    $148.21B
    GSK market capitalization is currently -47.93% below its historical high of $148.21 billion

    Market cap sector rank

    98.02%
    GSK market capitalization is higher than 98.02% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -0.35%
    GSK shares outstanding is down -0.35% year-on-year

    Shares Outstanding 3-Year Change

    -0.06%
    GSK shares outstanding is down -0.06% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.23
    GSK beta is 0.23

    200-day SMA

    $36.98
    GSK price is currently +2.67% above its 200-day simple moving average

    50-day SMA

    $38.95
    GSK price is currently -2.51% below its 50-day simple moving average

    RSI

    48.35
    GSK 14-day relative strength index is 48.35

    Volume

    0.68
    GSK 30-day relative volume is 0.68

    ATR

    $0.88
    GSK average true range is $0.88

    10-day Historical Volatility

    33.03%
    GSK 10-day historical volatility is 33.03%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.43
    GSK last dividend was $0.43 per share, with an ex-dividend date of May 16, 2025

    Next Dividend

    -
    GSK next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $1.56
    GSK annual dividend per share is $1.56

    Dividend per share Sector Rank

    57.65%
    GSK annual dividend per share is higher than 57.65% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +11.14%
    GSK annual dividend per share is up +11.14% year-on-year

    Dividend per share 3-Year Change

    -30.99%
    GSK annual dividend per share is down -30.99% over the past 3 years

    Dividend yield

    Dividend yield

    4.11%
    GSK annual dividend yield is 4.11%

    Dividend yield Sector Rank

    82.14%
    GSK annual dividend yield is higher than 82.14% of companies in Healthcare sector

    Other

    Payout ratio

    94.91%
    GSK annual payout ratio is 94.91%

    Dividends paid

    $3.12B
    GSK annual dividends paid is $3.12 billion

    Free cash flow

    $4.57B
    GSK annual free cash flow is $4.57 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $40.10B
    GSK annual revenue is $40.10 billion

    Revenue Analysts estimate

    $32.21B
    GSK annual revenue is currently +24.51% higher than the consensus analysts' forecast

    Revenue 1-year change

    +6.26%
    GSK annual revenue is up +6.26% year-on-year

    Revenue Sector rank

    97.25%
    GSK annual revenue is higher than 97.25% of companies in Healthcare sector

    EPS

    EPS

    $1.59
    GSK annual earnings per share is $1.59

    EPS Analysts estimate

    $4.38
    GSK annual earnings per share is currently -63.66% lower than the consensus analysts' forecast

    EPS 1-year change

    -46.72%
    GSK annual earnings per share is down -46.72% year-on-year

    EPS Sector rank

    91.2%
    GSK annual earnings per share is higher than 91.2% of companies in Healthcare sector

    Profit

    Gross profit

    $28.54B
    GSK annual gross profit is $28.54 billion

    Gross margin

    71.16%
    GSK annual gross profit margin is 71.16%

    Operating profit

    $5.14B
    GSK annual operating income is $5.14 billion

    Operating margin

    12.82%
    GSK annual operating profit margin is 12.82%

    Net income

    $3.29B
    GSK annual net profit is $3.29 billion

    Net margin

    8.21%
    GSK annual net profit margin is 8.21%

    Expenses

    Total expenses

    $34.96B
    GSK annual total expenses is $34.96 billion

    Operating expenses

    $23.40B
    GSK annual total operating expenses is $23.40 billion

    Cost of goods sold

    $11.56B
    GSK annual cost of goods sold is $11.56 billion

    Selling, general & administrative expenses

    $14.08B
    GSK annual SGA is $14.08 billion

    Depreciation and amortization

    $3.26B
    GSK annual depreciation & amortization is $3.26 billion

    Interest expense

    $817.94M
    GSK annual interest expense is $817.94 million

    Income tax

    $672.25M
    GSK annual income tax is $672.25 million

    EBIT & EBITDA

    EBIT

    $5.30B
    GSK annual earnings before interest & taxes is $5.30 billion

    EBITDA

    $9.11B
    GSK annual EBITDA is $9.11 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $74.61B
    GSK annual total assets is $74.61 billion

    Non current assets

    $53.29B
    GSK annual long term assets is $53.29 billion

    Current assets

    $21.33B
    GSK annual total current assets is $21.33 billion

    Cash and cash equivalents

    $4.63B
    GSK annual cash & cash equivalents is $4.63 billion

    Accounts receivable

    $6.98B
    GSK annual accounts receivable is $6.98 billion

    Inventory

    $7.11B
    GSK annual inventory is $7.11 billion

    Liabilities

    Total liabilities

    $58.19B
    GSK annual total liabilities is $58.19 billion

    Long term liabilities

    $30.97B
    GSK annual total long term liabilities is $30.97 billion

    Current liabilities

    $27.23B
    GSK annual total current liabilities is $27.23 billion

    Accounts payable

    $4.34B
    GSK annual accounts payable is $4.34 billion

    Debt

    Total debt

    $21.31B
    GSK annual total debt is $21.31 billion

    Total debt 1-year change

    -7.14%
    GSK annual total debt is down -7.14% year-on-year

    Long term debt

    $18.37B
    GSK annual long term debt is $18.37 billion

    Short term debt

    $2.95B
    GSK annual short term debt is $2.95 billion

    Equity & Capital

    Shareholders equity

    $17.15B
    GSK annual stockholders equity is $17.15 billion

    Book value

    $17.15B
    GSK annual book value is $17.15 billion

    Retained earnings

    $9.78B
    GSK annual retained earnings is $9.78 billion

    Working capital

    -$5.90B
    GSK annual working capital is -$5.90 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $8.38B
    GSK annual cash flow from operations is $8.38 billion

    Cash from operations 1-year change

    -0.54%
    GSK annual cash flow from operations is down -0.54% year-on-year

    Cash from investing

    -$1.57B
    GSK annual cash flow from investing activities is -$1.57 billion

    Cash from investing 1-year change

    +20.86%
    GSK annual cash flow from investing activities is up +20.86% year-on-year

    Cash from financing

    -$6.04B
    GSK annual cash flow from financing activities is -$6.04 billion

    Cash from financing 1-year change

    +13.95%
    GSK annual cash flow from financing activities is up +13.95% year-on-year

    CAPEX

    CAPEX

    $3.81B
    GSK annual capital expenditures is $3.81 billion

    CAPEX 1-year change

    +30.67%
    GSK annual capital expenditures is up +30.67% year-on-year

    Free Cash Flow

    Free cash flow

    $4.57B
    GSK annual free cash flow is $4.57 billion

    Free cash flow 1-year change

    -17.07%
    GSK annual free cash flow is down -17.07% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    71.16%
    GSK annual gross profit margin is 71.16%

    Operating margin

    12.82%
    GSK annual operating profit margin is 12.82%

    Net margin

    8.21%
    GSK annual net profit margin is 8.21%

    ROA & ROE

    ROA

    4.39%
    GSK annual return on assets is 4.39%

    ROE

    20.12%
    GSK annual return on equity is 20.12%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    19.69
    GSK price to earnings ratio is 19.69

    PE ratio Sector rank

    39.15%
    GSK price to earnings ratio is higher than 39.15% of companies in Healthcare sector

    PB Ratio

    PB ratio

    4.21
    GSK price to book ratio is 4.21

    PB ratio Sector rank

    75.12%
    GSK price to book ratio is higher than 75.12% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.92
    GSK price to sales ratio is 1.92

    PS ratio Sector rank

    36.8%
    GSK price to sales ratio is higher than 36.8% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $95.24B
    GSK enterprise value is $95.24 billion

    Enterprise value Sector rank

    98.25%
    GSK enterprise value is higher than 98.25% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    9.76
    GSK EV/EBITDA is 9.76

    EV/EBITDA Sector rank

    82.76%
    GSK EV/EBITDA is higher than 82.76% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.78
    GSK annual current ratio is 0.78

    Quick ratio

    0.52
    GSK annual quick ratio is 0.52

    Leverage

    Debt to equity

    1.24
    GSK annual debt to equity ratio is 1.24

    Interest coverage ratio

    6.48
    GSK annual interest coverage ratio is 6.48

    Risk & Stability

    Piotroski F-Score

    6
    GSK piotroski f-score is 6

    Altman Z-Score

    1.66
    GSK altman z-score is 1.66

    Analyst ratings

    Recent major analysts updates

    Nov 12, 24 Jefferies
    Hold
    Oct 31, 24 Guggenheim
    Neutral
    Jul 8, 24 UBS
    Neutral
    Jul 2, 24 Jefferies
    Buy
    May 30, 24 Goldman Sachs
    Neutral
    Mar 4, 24 Guggenheim
    Buy
    Jan 23, 24 Morgan Stanley
    Equal-Weight
    Jan 3, 24 Jefferies
    Buy
    Feb 11, 22 DZ Bank
    Hold
    Nov 5, 21 Barclays
    Equal-Weight

    Institutional Ownership

    Screeners with GSK included

    High Piotroski score stocks
    UK stocks
    Healthcare sector
    All stocks
    High yield dividend stocks
    Companies with buyback
    Best performing stocks YTD
    Ex Dividend dates calendar
    Earnings next week
    NYSE Companies
    • What is the ticker symbol for GSK plc?
    • Does GSK plc pay dividends?
    • What sector is GSK plc in?
    • What industry is GSK plc in?
    • What country is GSK plc based in?
    • When did GSK plc go public?
    • Is GSK plc in the S&P 500?
    • Is GSK plc in the NASDAQ 100?
    • Is GSK plc in the Dow Jones?
    • When was GSK plc's last earnings report?
    • When does GSK plc report earnings?

    What is the ticker symbol for GSK plc?

    The ticker symbol for GSK plc is NYSE:GSK

    Does GSK plc pay dividends?

    Yes, GSK plc pays dividends. The last payment was $0.43, with an ex-dividend date on May 16, 2025

    What sector is GSK plc in?

    GSK plc is in the Healthcare sector

    What industry is GSK plc in?

    GSK plc is in the General Drug Manufacturers industry

    What country is GSK plc based in?

    GSK plc is headquartered in United Kingdom

    When did GSK plc go public?

    GSK plc's initial public offering (IPO) was on March 28, 1980

    Is GSK plc in the S&P 500?

    No, GSK plc is not included in the S&P 500 index

    Is GSK plc in the NASDAQ 100?

    No, GSK plc is not included in the NASDAQ 100 index

    Is GSK plc in the Dow Jones?

    No, GSK plc is not included in the Dow Jones index

    When was GSK plc's last earnings report?

    GSK plc's most recent earnings report was on April 30, 2025

    When does GSK plc report earnings?

    The next expected earnings date for GSK plc is July 30, 2025
    On this page